REPROS THERAPEUTICS INC's ticker is and the CUSIP is 76028H909. A total of 2 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $276,000 | -86.6% | 2,277 | -18.0% | 0.02% | -82.4% |
| Q3 2015 | $2,063,000 | +26.7% | 2,777 | +22.0% | 0.08% | +44.1% |
| Q2 2015 | $1,628,000 | +8.1% | 2,277 | +29.9% | 0.06% | -6.3% |
| Q1 2015 | $1,506,000 | -13.6% | 1,753 | +0.3% | 0.06% | +14.5% |
| Q4 2014 | $1,743,000 | +62.0% | 1,748 | +60.8% | 0.06% | +34.1% |
| Q3 2014 | $1,076,000 | +121.9% | 1,087 | +310.2% | 0.04% | +32.3% |
| Q4 2013 | $485,000 | -79.1% | 265 | -69.4% | 0.03% | -79.5% |
| Q3 2013 | $2,318,000 | +528.2% | 865 | +332.5% | 0.15% | +504.0% |
| Q2 2013 | $369,000 | – | 200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 200 | $369,000 | 0.02% |
| Citadel Advisors | 38,200 | $705,000 | 0.00% |